Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples